I
ncreased attention to providing adequate pain control as well as to patient satisfaction rankings 1 has placed postoperative pain control in the forefront. Coupled with the epidemic of opioid abuse and drug diversion, the use of appropriate narcotic dosing combined with nonnarcotic alternatives has received increased attention. While there has been a quadrupling of deaths from prescription narcotic pain killers, 2 patients' perception of the surgical experience can be negatively affected by poor pain control and narcotic side effects such as nausea, vomiting, constipation, and sedation.
Other surgical subspecialties such as orthopedics and breast surgery have embraced new options for better managing postoperative pain. 3, 4 Multimodal pain management, the coadministration of 2 or more drugs that act by different mechanisms to provide analgesia is growing in use. Drugs with diverse mechanisms of action are combined in different regimens starting before, during, and after surgery to achieve better postoperative pain control. Adjuvant pain management with drugs whose traditional use is not for pain also demonstrates effectiveness in reducing discomfort when used in the postoperative setting.
Preemptive analgesia is any treatment given to the patient prior to surgery.
For the purposes of this review, we included interventions that were complete prior to the end of the hysterectomy. Theories exist that giving medications preemptively can prevent central sensitization caused by an incision and inflammation. Medications vary and can be administered via many routes (including orally, rectally, intravenously, intrathecallly, subcuticularly, subcutaneously, intramuscularly), at various times, and at different dosages of narcotics [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] and nonnarcotic medications. [15] [16] [17] [18] [19] [20] With this broad range of options, decisions about postoperative pain control should take into account the factors associated with different surgeries in different patient populations to best achieve success.
Objectives of the study Our aim was to systematically review current studies with a primary outcome of pain control in women receiving any preemptive medication at the time of abdominal hysterectomy to determine the best method of pain control postoperatively to decrease narcotic consumption and adverse events. Comparators were placebo, same medication as intervention, or other nonnarcotic or narcotic medication.
Materials and Methods
The Society of Gynecologic Surgeons Systematic Review Group includes members with expertise in gynecological surgery and in the conduct of systematic reviews and guideline development. This was performed in conjunction with a specialized methodologist who is a physician but not a gynecological surgeon with expertise conducting systematic reviews including designing and implementing electronic literature searches.
Data sources and searches
We searched MEDLINE, Cochrane Central Register for Controlled Trials, and Cochrane Database of Systematic Reviews from inception through May 31, 2016 . Search terms included a range of narcotic and nonnarcotic analgesics, other adjuvant medications used in conjunction with narcotics, gynecological surgeries and conditions, and filters for comparative studies and systematic reviews (Supplemental Table) . The search was further limited to human and English-language studies. Meeting abstracts were excluded. The reference lists from relevant systematic reviews were examined for additional studies. Study authors were not contacted.
Ten reviewers independently doublescreened the abstracts using the computerized screening program Abstrackr 21 after consensus testing was performed on pilot sets of 100 abstracts. During abstract screening, trials of any perioperative analgesic (including preoperative, operative, and postoperative) were included. Abstrackr is a program that was developed specifically to screen article title and abstract (if available) for systematic reviews and other similar projects.
Potentially relevant studies were categorized based on analgesia and timing and type of intervention. Based on these results, this systematic review was restricted to the use of preemptive medications for pain control for abdominal hysterectomy. Full-text extractions were then performed independently by 2 reviewers, with any discrepancies adjudicated by a third reviewer.
Study selection
After focusing the original search, the final review included randomized controlled trials (RCTs) of preemptive medications given prior to the completion of abdominal hysterectomy for both benign and malignant indications with the intention of controlling pain or minimizing narcotic usage (Figure) . The preemptive medication regimens had to be compared with other regimens including placebo. Trials that evaluated pain control or narcotic minimization as secondary objectives or trials that compared surgical techniques were excluded.
Because we were focused on decision making by surgical gynecologists, we excluded studies of medications given only by anesthesiologists such as inhalant anesthetics, spinal/epidural medications, or other forms of nerve block. Studies were required to report on pain assessment, postoperative narcotic usage, or patient satisfaction at a minimum of 3 hours postoperatively, such that it would extend past a typical postanesthesia care unit stay. We also collected adverse event and cost data. No sample size, publication date, or country restrictions were made.
Data extraction and quality assessment Data were extracted by 1 of 10 reviewers using a standardized data extraction form and confirmed by another reviewer; discrepancies were resolved by consensus. The intervention was categorized as narcotic, nonnarcotic, and placebo medication; and data extracted included study characteristics, participant characteristics, intervention details (dosage, drug category, route of administration), length of follow-up, cost, and results. We assessed the methodological quality of each RCT based on Cochrane risk of bias tool for RCTs. 22 Grades for different outcomes could vary within the same study.
Data synthesis and analysis
For each outcome, we graded the quality of evidence according to the Grades for Recommendation, Assessment, Development, and Evaluation system. 23 The process considered the methodological quality, consistency of results across studies, directness, and imprecision or sparseness of evidence to determine an overall evidence quality. Grades for different outcomes could vary within the same study.
We developed clinical practice guidelines (CPGs), incorporating the balance between benefits and harms of the compared interventions when the data were sufficient to support these statements. Each guideline was assigned an overall strength of the recommendation (1, strong; and 2, weak) and a quality of evidence (4 quality-rating categories were possible: high Recommendation strength indicates the extent to which one can be confident Systematic Reviews ajog.org that adherence to the recommendation will do more good than harm. Thus, the strongest recommendation assigned to a CPG would be 1A and the lowest 2D. In formation of the CPGs, the term recommend was used for level 1 and suggest for level 2. The CPGs can be found in Table 1 .
We presented our findings at the 41st annual scientific meeting of the Society of Gynecologic Surgeons. A link to the guidelines and manuscript was then e-mailed to the entire membership of the Society of Gynecologic Surgeons for final review and vetting prior to final editing.
Results
For this review, 2486 abstracts were screened, with 249 full-text manuscripts accepted in our initial extraction. Study selection including preoperative, operative, and postoperative intervention timing was included in the preliminary extraction. The review was then focused on preemptive and preoperative interventions only. Eighty-four articles meeting those criteria were then extracted in more detail, and ultimately 69 fulltext manuscripts were included. Of these, 20 had an active narcotic comparison while the rest had nonnarcotic comparison. Some studies had multiple arms comparing variables such as different medication, combination of medications, placebo, timing, dosing, and route of administration.
Nonnarcotic medications
In the studies that included an active nonnarcotic arm, there were 46 comparative arms comparing nonnarcotic medication with placebo. The remainder of the comparative arms looked at medication A vs medication B, medication combinations, alternative dosing, and timing. Of these, only paracetamol (acetaminophen outside the United States), gabapentin, and rofecoxib combined with gabapentin demonstrated improved pain assessments ( Table 2) .
Ten studies compared a nonnarcotic with another nonnarcotic. One study comparing pregablin with lorazepam demonstrated improved pain levels using pregablin. Nonsteroidal antiinflammatory drugs (NSAIDs) had variable results when compared with each other, although indomethacin, meloxicam, and ibuprofen all had a better effect on pain compared with placebo. Bupivicaine injection when placed as a transversus abdominis plane block was more effective than intravenous or subdermal infiltration for pain control (Table 2) .
Looking at postoperative narcotic usage for women administered nonnarcotic medications compared with those given placebo, preemptive use of paracetamol, gabapentin, bupivacaine, and phenothiazine resulted in less overall narcotic usage. NSAIDs and rofecoxib had variable results. Benzodiazepines were not better than placebo at reducing the amount of narcotic needed. Women who received gabapentin plus paracetamol used fewer narcotics than those who had gabapentin alone. A bupivacaine transversus abdominis plane block resulted in lower narcotic requirements for patients than bupivacaine Clinical practice guidelines for use of preemptive medications for reduction of pain following abdominal hysterectomy
We recommend the use of preemptive medication prior to abdominal hysterectomy to: decrease postoperative narcotic consumption (1A)* improve patient satisfaction (2B) * paracetamol (ie, acetaminophen), gabapentin, and rofecoxib combined with gabapentin 2. When planning an abdominal hysterectomy and choosing among the options for a preemptive pain medication, we suggest specifically gabapentin, paracetamol, NSAIDs, COX-2 inhibitors or narcotics used individually (1A) or in combination (2A). If using narcotics, we suggest using higher preemptive doses to result in lower postoperative narcotic requirements (2B) We suggest use of preemptive NSAIDS for reduction of pain (2A) and total postoperative narcotic consumption (2A) We suggest use of preemptive COX-2 inhibitors for reduction of total postoperative narcotic consumption (2A) and improved patient satisfaction (2A) 3 . In patients at a higher risk of nausea and vomiting, we recommend the addition of preemptive phenothiazine medication (1A).
4. Because there is no risk of increased blood loss, length of procedure, or duration of hospital stay with use of preemptive pain medications, we suggest these concerns should not preclude use (2A).
COX-2, cyclooxygenase-2; NSAID, nonsteroidal antiinflammatory drug.
Steinberg. Preemptive analgesia for postoperative hysterectomy pain control. Am J Obstet Gynecol 2017. ajog.org Systematic Reviews administered intravenously or subdermally (Table 3) . Satisfaction rates were higher in women given gabapentin combined with paracetamol than those who were given gabapentin alone.
Rofecoxib resulted in improved patient satisfaction compared with gabapentin. Benzodiazepines, clonidine, and ibuprofen did not differ from placebo for patient satisfaction measures.
Narcotic medications
Nineteen studies evaluated the use of preemptive narcotic medications for hysterectomy. Of these, 5 compared with placebo; 2 compared with a nonnarcotic; and the remainder had (Table 4 ). In the narcotic vs placebo studies, all narcotics (ketamine, morphine, fentanyl) resulted in improved pain control. Narcotics also resulted in better improvements in pain scores than did nonnarcotic medications, which included NSAIDs and paracetamol. In studies comparing specifically morphine with other narcotics, methadone and nalbutaine had a greater effect at pain score reduction than morphine. Buprenorphine, fentanyl, and morphine demonstrated equally positive effects on pain assessment when analyzed at various doses (Table 4) .
For overall postoperative narcotic use, 4 studies compared preemptive narcotic with placebo, 2 studies compared a preemptive narcotic with nonnarcotic medications, and 11 studies evaluated preemptive narcotics with other preemptive narcotics. Overall, preemptive narcotics, which included ketamine, morphine, and fentanyl in these studies, resulted in less total narcotic usage compared with placebo in the immediate postoperative period.
Similar results were seen with narcotics compared with NSAIDs. Preemptive methadone and nalbutaine were superior to morphine for the reduction of total narcotic usage when directly compared. Preemptive ketamine injections were more effective than postprocedure injections of ketamine or morphine at decreasing total narcotic usage. Higher doses of preemptive buprenorphine, fentanyl, and morphine resulted in patients ultimately having lower overall total narcotic requirements (Table 5) . 
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Other outcomes Intraoperative blood loss, length of surgery, and length of hospital stay were evaluated in 9 studies including placebo vs narcotic or nonnarcotic arms. All studies showed no difference compared with placebo (Table 6) . Sedation was evaluated in 7 nonnarcotic vs placebo studies, and no difference was found. Two studies evaluated preemptive narcotic vs nonnarcotic medications, and both favored nonnarcotics regarding sedation effects.
Postoperative nausea and vomiting were evaluated in 39 nonnarcotic studies and 10 narcotic studies. Phenothiazines as a class when given preemptively compared with placebo were the only medications that resulted in less nausea and vomiting postoperatively. There was no difference in postoperative nausea and vomiting with any other preemptive narcotic or nonnarcotic medication (Table 6 ).
There were insufficient data on cost to analyze.
Comment
Preemptive nonnarcotic and narcotic medications prior to abdominal hysterectomy decrease total narcotic requirements and improve patient postoperative pain assessment and satisfaction scores. These results take on an increased importance because inadequate pain control can result in extended hospital stay, readmission, a delayed return to normal daily activities, a decreased ambulation, and overall increased morbidity, ultimately resulting in decreased patient and surgeon satisfaction. [24] [25] [26] Under the Affordable Care Act, limiting readmission and better controlling pain is directly linked to both hospital and physician reimbursement, and patient satisfaction scores are becoming ajog.org Systematic Reviews increasingly available to savvy patients. 27 When considering the use of preemptive nonnarcotic medications for abdominal hysterectomy patients, some, such as clonidine, benzodiazepam, and cimetidine, showed no reduction in postoperative validated pain score assessment compared with placebo. While NSAIDs, cyclooxygenase-2 (COX-2) inhibitors, gabapentin and paracetamol have shown an improvement in postoperative pain scores, decreasing narcotic usage, and patient satisfaction compared with placebo, this effect did not persist when compared with narcotics. There is no increased risk of postoperative nausea/vomiting, sedation, prolongation of operative procedure, blood loss, or length of stay.
Nonnarcotics provided less sedative side effects than did preemptive narcotics. Overall, when choosing a preemptive nonnarcotic medication to control pain after abdominal hysterectomy, this review supports the use of an NSAID, COX-2 inhibitor, gabapentin, and/or paracetamol.
Intravenous paracetamol is an effective preemptive therapy compared with placebo at improving pain scores, improving patient satisfaction, and reducing overall narcotic usage. It is not different from narcotics, gabapentin, or in combination with other medications for outcomes. Overall, when considering the use of preemptive paracetamol, especially in light of the recent dramatic increase in cost associated with its use, 28 we recommend the use of gabapentin or narcotics as equivalent alternatives.
The use of NSAIDs as a preemptive medication, specifically ibuprofen, indomethacin, and meloxicam, demonstrates effective pain reduction. Some NSAIDs have also been shown to decrease total narcotic consumption, including naproxen, meloxicam, indomethacin, lornoxicam, ketoprofen, and tenoxicam. There are insufficient data to assess the effect of NSAIDs on patient satisfaction. Meloxicam and indomethacin both have been shown to decrease pain and total narcotic consumption and should be considered for first-line use. The use of COX-2 inhibitors preemptively does not decrease postoperative pain but does decrease total narcotic consumption and provides improved patient satisfaction in the immediate postoperative period.
It is for these reasons we suggest the preemptive use of NSAIDs, specifically indomethacin and meloxicam, for reduction of pain and total postoperative narcotic consumption and COX-2 inhibitors for reduction of total narcotic Medications in the phenothiazine class, such as prochlorperazine and promethazine, do not seem to significantly decrease postoperative pain. However, these medications do demonstrate decreased nausea and vomiting in some patients at increased risk. For patients with a high concern for nausea with narcotic use or a reported history of postoperative nausea and vomiting, preemptive phenothiazine may be considered combined with adequate pain medication, balancing possible cognitive side effects.
Concerns that preemptive medications can contribute to increased blood loss, length of procedure, or duration of hospital stay were not supported by our review. These concerns, along with those about the use of oral medications preoperatively, should not preclude the use of preemptive medications prior to abdominal hysterectomy. For concerns about potential sedation, we suggest preferential use of nonnarcotics to limit the need for narcotic medications in the posoperative period.
The strength of this review is the use of a large number of high-quality RCTs pertaining specifically to gynecological surgery combined with our rigorous systematic review methods and experience at this process. Additionally, we had a large number of patient-focused outcomes to evaluate. Many of the conclusions drawn were of high quality, leading to strong clinical practice guidelines. To make this process as homogenous as possible and therefore strengthen our recommendations, we narrowed the scope to the use of preemptive medications for abdominal hysterectomy. To our knowledge this is the first systematic review of preemptive medications for pain control for abdominal hysterectomy.
Like all systematic reviews, our results are limited by the studies available to our use. Factors such as abdominal incision type and concomitant procedure were not consistently available to report, which may have influenced the conclusions generated. Additionally, those patients with gynecological malignancies could have skewed the data because these patients will have a tendency to have a larger with more complex procedures influencing pain scores and medication use. Given our decision to focus the review, the conclusions may not be applicable to other routes of hysterectomy or other gynecological procedures. Care should be taken when attempting to apply our results to other modes of hysterectomy.
It was also difficult to draw conclusions on combinations of medications because few studies provided these data. There was not a large amount of data concerning adverse events or cost that could be analyzed. Multimodal preemptive analgesia has been well described in other specialties but is unfortunately a newer concept for gynecology, and this should provide a focus for future study. Specifically, studies of the use of preemptive medication for other more minimally invasive gynecological surgeries including vaginal and laparoscopic hysterectomies would be valuable. It is our belief that further research is needed specifically looking at surgeon-applied nerve blocks and abdominal wall infiltration and on a larger picture-enhanced recovery pathway.
In conclusion, the use of preemptive medications for a total abdominal hysterectomy is effective in decreasing total narcotic required and improving patients' postoperative pain assessment and satisfaction.
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